These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29520646)

  • 21. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
    Kelly KJ; Winslow E; Kooby D; Lad NL; Parikh AA; Scoggins CR; Ahmad S; Martin RC; Maithel SK; Kim HJ; Merchant NB; Cho CS; Weber SM
    J Gastrointest Surg; 2013 Jul; 17(7):1209-17; discussion 1217. PubMed ID: 23620151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
    Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
    Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the left renal vein as a practical conduit in superior mesenteric vein reconstruction.
    Choudry H; Avella D; Garcia L; Han D; Staveley-O'Carroll K; Kimchi E
    J Surg Res; 2008 May; 146(1):117-20. PubMed ID: 18028958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability.
    Cheung TT; Poon RT; Chok KS; Chan AC; Tsang SH; Dai WC; Chan SC; Fan ST; Lo CM
    World J Gastroenterol; 2014 Dec; 20(46):17448-55. PubMed ID: 25516657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy.
    Katz MH; Fleming JB; Pisters PW; Lee JE; Evans DB
    Ann Surg; 2008 Dec; 248(6):1098-102. PubMed ID: 19092356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion].
    Kriger AG; Karmazanovsky GG; Smirnov AV; Kharazov AF; Gorin DS; Raevskaya MB; Galkin GV; Revishvili AS
    Khirurgiia (Mosk); 2018; (12):21-29. PubMed ID: 30560841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
    Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
    Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study.
    Hackert T; Strobel O; Michalski CW; Mihaljevic AL; Mehrabi A; Müller-Stich B; Berchtold C; Ulrich A; Büchler MW
    HPB (Oxford); 2017 Nov; 19(11):1001-1007. PubMed ID: 28838632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Mizuno S; Kato H; Yamaue H; Fujii T; Satoi S; Saiura A; Murakami Y; Sho M; Yamamoto M; Isaji S
    Ann Surg; 2021 Jul; 274(1):e36-e44. PubMed ID: 31356273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.
    Shyr BU; Chen SC; Shyr YM; Wang SE
    Surg Endosc; 2020 Jan; 34(1):377-383. PubMed ID: 30963260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
    Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
    Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
    HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior mesenteric-portal vein resection during laparoscopic pancreatoduodenectomy.
    Khatkov IE; Izrailov RE; Khisamov AA; Tyutyunnik PS; Fingerhut A
    Surg Endosc; 2017 Mar; 31(3):1488-1495. PubMed ID: 27444832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
    Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
    J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?
    Clanton J; Oh S; Kaplan SJ; Johnson E; Ross A; Kozarek R; Alseidi A; Biehl T; Picozzi VJ; Helton WS; Coy D; Dorer R; Rocha FG
    HPB (Oxford); 2018 Oct; 20(10):925-931. PubMed ID: 29753633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.